Magnesium Bisglycinate Chelate
Goals
$19.99 $0.33 per serving
Product analysis
Magnesium Bisglycinate Chelate provides a favorably absorbed magnesium source at good value and can help fill a dietary shortfall affecting normal energy and bone metabolism.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality100
The magnesium is supplied as clearly identified bisglycinate, with favorable support for absorption. That does not establish a separate advantage for stress, hormone or heart outcomes.
Ingredient Transparency100
The magnesium amount and preparation are clearly stated. Buyers can readily compare the declared serving with other magnesium supplements.
Value For Money100
The magnesium contribution offers good value. Its single active ingredient makes the cost comparison straightforward.
Customer Satisfaction69
Customers report high satisfaction across more than a hundred ratings. That provides useful initial context, although the customer base is still modest.
Product Focus57
The clearest role is correcting low magnesium intake to support normal energy and mineral functions. Effects on stress, testosterone and cardiovascular outcomes remain more uncertain.
- Format
Tablet - Container
- 120 Tablet(s)
- Per serving
- $0.33
- Customer rating
- 4.6 · 122 ratings
Goals
Impact
High effect
Magnesium · 200 mg
Magnesium contributes to normal energy and mineral functions when dietary intake falls short. Higher amounts do not establish extra benefit once intake is adequate.
How this product is rated for Everyday Health
Ingredient fit72
The known ingredients have a focused relationship to the retained nutritional functions. Some amounts fall below the comparison references or remain unresolved.
Goal fit
The retained ingredients closely match the comparison focus; this describes nutritional relevance rather than comprehensive health improvement.
Dose adequacy
The retained amounts provide partial or unresolved coverage of the saved comparison references, rather than demonstrating complete nutritional intake.
Pathways40
The strongest retained connection is energy metabolism cofactors. Coverage of other functions is narrower.
Depth
The strongest retained connection is energy metabolism cofactors, based on the known ingredient amounts.
Breadth
The contribution is concentrated in energy metabolism cofactors, with limited coverage of other retained functions.
Evidence86
Magnesium provides the strongest retained evidence. The supplied context supports nutritional availability or limited population-specific findings, without establishing broad health improvements beyond adequate intake.
Evidence strength
Magnesium supplies the strongest retained evidence. Its supplied context limits expectations to nutritional or population-specific outcomes.
Studied preparation
The retained preparations match the saved criteria; no superiority of chemical form or delivery is established.
Formulation logic100
The supplied checks identify no configured conflict or missing required partner. The retained amount thresholds remain comparison references rather than treatment doses.
Partner coverage
The retained ingredients have no missing required partner under the saved criteria; this does not establish an added combination benefit.
Conflicts
No configured ingredient conflict was identified from the supplied amounts.
Effective doses
The retained amounts meet the saved minimum comparison threshold, which is not proof of a clinical effective dose.
Impact
High effect
Magnesium · 200 mg
Magnesium has a conditional connection to stress relief, particularly in people with low magnesium status or selected clinical circumstances. Broad, lasting everyday relief remains uncertain. The disclosed serving contributes to the saved calming-related finding, but its amount is not a measured probability of benefit, and the salt name does not establish superior stress outcomes.
How this product is rated for Stress Relief
Ingredient fit72
Magnesium is a key ingredient in the saved stress-related findings. Amounts provide partial or uneven support.
Goal fit
Magnesium gives the formula a focused connection to stress-related outcomes, alongside its other linked uses.
Dose adequacy
The disclosed amounts provide partial or uneven support to the saved stress-related findings.
Pathways15
The strongest coverage concerns calming-related activity. No route reaches the breadth criterion.
Depth
The strongest saved coverage concerns calming-related activity; this does not establish a lasting clinical effect.
Breadth
No evaluated route reaches the breadth criterion; support remains focused and partial.
Evidence76
Magnesium’s stress support is conditional on low status or selected clinical settings; lasting everyday relief remains uncertain.
Evidence strength
Magnesium’s stress support is conditional on low status or selected clinical settings; lasting everyday relief remains uncertain.
Studied preparation
The credited ingredients meet the saved preparation criteria; population, duration and outcome differences still limit expectations.
Formulation logic100
The credited ingredients meet the minimum amount criterion, with no unmet partner requirement or evaluated ingredient conflict identified.
Partner coverage
No credited ingredient has an unmet partner requirement; this does not establish extra relief from combining ingredients.
Conflicts
No ingredient conflict was identified by the evaluated rules.
Effective doses
All credited ingredients meet the saved minimum amount criterion; this is not a proven effective dose or response threshold.
Impact
Moderate effect
Magnesium · 200 mg
Magnesium at 200 mg supports normal energy metabolism and helps address a dietary gap associated with tiredness. Bisglycinate delivery does not establish an additional energy benefit when magnesium intake is adequate.
How this product is rated for Energy
Ingredient fit72
The saved assessment finds a concentrated nutritional contribution to the energy goal. The assessed amounts provide partial support against the saved dose references (50 out of 100).
Goal fit
The saved assessment finds a concentrated nutritional contribution to the energy goal.
Dose adequacy
The assessed amounts provide partial support against the saved dose references (50 out of 100).
Pathways0
No direct energy mechanism has recorded coverage; the assessed contribution is nutritional. No direct energy mechanism reaches the saved coverage threshold.
Depth
No direct energy mechanism has recorded coverage; the assessed contribution is nutritional.
Breadth
No direct energy mechanism reaches the saved coverage threshold.
Evidence88
Magnesium leads the saved evidence comparison at an assessed amount. The saved assessment places the qualifying ingredients in its studied-preparation category.
Evidence strength
Magnesium leads the saved evidence comparison at an assessed amount.
Studied preparation
The saved assessment places the qualifying ingredients in its studied-preparation category.
Formulation logic100
The assessed ingredients work independently or have their listed partner. No ingredient conflict is recorded in the saved assessment.
Partner coverage
The assessed ingredients work independently or have their listed partner.
Conflicts
No ingredient conflict is recorded in the saved assessment.
Effective doses
All assessed ingredients reach the saved minimum dose threshold.
Impact
High effect
Magnesium · 200 mg
Magnesium supports normal bone metabolism and can fill a dietary intake gap. The 200 mg per serving provides partial nutritional support. The supplied evidence does not establish routine fracture or osteoporosis prevention, or a superior bone effect from its mineral form.
How this product is rated for Bone Health
Ingredient fit72
The 200 mg magnesium serving provides partial nutritional coverage.
Goal fit
The declared actives focus on bone-related nutrient roles.
Dose adequacy
The 200 mg magnesium serving provides partial nutritional coverage.
Pathways19
Bone mineral supply is the strongest area. Mineral supply contributes partially, with no pathway reaching the saved coverage threshold.
Depth
Bone mineral supply is the strongest area.
Breadth
Mineral supply contributes partially, with no pathway reaching the saved coverage threshold.
Evidence95
Magnesium leads the saved evidence finding through nutritional support; routine fracture prevention is not established.
Evidence strength
Magnesium leads the saved evidence finding through nutritional support; routine fracture prevention is not established.
Studied preparation
Counted ingredients with sufficient amounts were treated as matching reviewed preparations; that does not establish reliable fracture protection.
Formulation logic100
The counted ingredients have no unmet partner requirement; this does not establish extra benefit from combining them. No conflict was matched by the supplied checks.
Partner coverage
The counted ingredients have no unmet partner requirement; this does not establish extra benefit from combining them.
Conflicts
No conflict was matched by the supplied checks.
Effective doses
All counted ingredients meet the saved amount threshold, which is not a proven effective dose.
Impact
High effect
Magnesium · 200 mg
Magnesium helps regulate vascular tone and electrolyte balance. Its supplemental blood-pressure effects are small and inconsistent in the supplied evidence, so a noticeable change is uncertain. This serving supplies 200 mg of magnesium and receives partial amount recognition. Neither the named form nor the serving comparison establishes superior heart protection.
How this product is rated for Heart Health
Ingredient fit72
Magnesium is the sole credited active, with a narrow blood-pressure-related connection.
Goal fit
Magnesium is the sole credited active, with a narrow blood-pressure-related connection.
Dose adequacy
The 200 mg serving receives partial amount recognition rather than establishing a blood-pressure treatment dose.
Pathways19
The contribution is concentrated on electrolyte balance and vascular tone, with partial coverage.
Depth
The contribution is concentrated on electrolyte balance and vascular tone, with partial coverage.
Breadth
No main route reaches the saved breadth threshold.
Evidence89
Magnesium provides the evidence connection, but blood-pressure effects are marginal and inconsistent.
Evidence strength
Magnesium provides the evidence connection, but blood-pressure effects are marginal and inconsistent.
Studied preparation
The credited preparations pass the saved preparation check; this does not establish cardiovascular-event prevention.
Formulation logic100
The credited ingredients do not require an additional partner, and no configured conflicts were identified.
Partner coverage
The credited ingredients can contribute without an additional required partner.
Conflicts
No configured conflict was identified; this does not establish overall safety.
Effective doses
All credited ingredients meet the saved minimum amount threshold; that threshold is not a proven effective dose.
Impact
High effect
Magnesium · 200 mg
Magnesium may support blood-vessel function, with more plausible benefit when magnesium status is low or blood pressure is elevated. Trials of arterial stiffness and blood pressure have been inconsistent, including studies with no overall improvement. This serving supplies 200 mg of declared magnesium, below the 350 mg amount used in one positive stiffness trial. The chelated form does not establish superior cardiovascular effects or prevention of rhythm problems or cardiovascular events.
How this product is rated for Cardiovascular Support
Ingredient fit72
Magnesium provides a focused nutrient connection to cardiovascular support, with partial amount recognition.
Goal fit
Magnesium is the sole active, though its product is linked to several broader goals.
Dose adequacy
The 200 mg declared magnesium serving receives partial amount recognition relative to the higher trial reference.
Pathways17
The modest included connection concerns vascular tone and sodium balance, without broad cardiovascular coverage.
Depth
Vascular tone and sodium balance provide the strongest included connection, though clinical-marker findings are inconsistent.
Breadth
No cardiovascular route reaches the breadth requirement; the included connection remains modest and concentrated.
Evidence79
Magnesium has inconsistent vascular-marker findings. Its declared form receives recognition, without a superior cardiovascular effect assigned to chelated salts.
Evidence strength
Magnesium has inconsistent blood-pressure and stiffness findings, with greater plausibility in low-status or elevated-pressure settings.
Studied preparation
The declared magnesium form receives recognition; this does not establish superior cardiovascular effects over other salts.
Formulation logic100
Magnesium can contribute alone and meets the amount requirement. No assessed conflict was found.
Partner coverage
Magnesium can contribute without an added partner.
Conflicts
No assessed ingredient conflict was found in the supplied formulation.
Effective doses
Magnesium meets the amount requirement used for inclusion.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Magnesium (TRAACS Magnesium Bisglycinate Chelate) | 200 mg |
Magnesium (TRAACS Magnesium Bisglycinate Chelate) · 200 mg OverallScore96
Each serving provides 200 mg of magnesium as bisglycinate, a form assessed favorably for absorption potential. A named branded magnesium material is recorded, and a whole-product serving costs about $0.33.
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
Magnesium bisglycinate is assessed favorably for absorption potential. A qualifying branded magnesium material is recorded.
Magnesium Form & Absorption Potential
Bisglycinate is assessed favorably for absorption potential.
Patented Materials & Chelation Quality
A qualifying named branded magnesium material is recorded in the saved facts.
Dose, Safety & Label Transparency90
The serving specifies 200 mg of elemental magnesium.
Elemental Yield Transparency
The saved facts specify 200 mg of elemental magnesium per serving.
Therapeutic Dosage Alignment
The serving provides 200 mg of elemental magnesium.
Synergistic Formulation Logic
The saved facts record 0 mg of calcium and no positive qualifying cofactor.
Value100
A whole-product serving costs about $0.33; the magnesium value assessment is favorable for its form at that price.
Price Per Elemental Quality
A whole-product serving costs about $0.33; the magnesium value assessment is favorable for its form at that price.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Association between Serum Magnesium and Fractures: A Systematic Review and Meta-Analysis of Observational Studies.
- Bioabsorbable Magnesium-Based Materials Potential and Safety in Bone Surgery: A Systematic Review.
- Vascularized bone grafting fixed by biodegradable magnesium screw for treating osteonecrosis of the femoral head.
- An update on magnesium and bone health.
- Sex-specific differences in the association of magnesium intake with femoral neck bone mineral density among older adults.
- Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies.
- Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies.
- Quantitative Association Between Serum/Dietary Magnesium and Cardiovascular Disease/Coronary Heart Disease Risk: A Dose-Response Meta-analysis of Prospective Cohort Studies.
- Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
- Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.
- Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial.
- Total magnesium intake and risk of frailty in older women.
- Red blood cell magnesium and chronic fatigue syndrome.
- Exercise, magnesium and immune function.
- Perioperative systemic magnesium to minimize postoperative pain: a meta-analysis of randomized controlled trials.
- Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2).
- Association of magnesium sulfate use with mortality in critically ill patients with sepsis: a retrospective propensity score-matched cohort study.
- Hypomagnesemia and Mortality in Incident Hemodialysis Patients.
- The effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial.
- Efficacy of oral magnesium therapy in the treatment of chronic constipation in spastic cerebral palsy children: a randomized controlled trial.